Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Irritable Bowel Syndrome

In brief

A study of the efficacy and safety of Lubiprostone in subjects diagnosed with IBS-M/IBS-U.

Key facts

Study ID
NCT02544152
Run by
Sucampo Pharma Americas, LLC
People needed
71
Starts
2015-02-01
Expected to finish
2016-12-01
Last updated by the study team
2019-12-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.